These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6186259)

  • 1. LSD: effect on monoamine metabolites in rat prefrontal cortex.
    Bowers MB; Salomonsson LA
    Biochem Pharmacol; 1982 Dec; 31(24):4093-6. PubMed ID: 6186259
    [No Abstract]   [Full Text] [Related]  

  • 2. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
    Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
    Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of quipazine and LSD on monoamines in the rat striatum.
    Miśkiewicz M; Rokosz-Pelc A; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(5):489-92. PubMed ID: 94944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of chlorpromazine and its active metabolites in rat brain and the relationship to central monoamine metabolism and prolactin secretion.
    Alfredsson G; Wiesel FA; Skett P
    Psychopharmacology (Berl); 1977 Jun; 53(1):13-8. PubMed ID: 407609
    [No Abstract]   [Full Text] [Related]  

  • 5. D-lysergic acid diethylamide (LSD)--effect on biogenic amines excretion in man.
    Messiha FS; Grof S
    Biochem Pharmacol; 1973 Sep; 22(18):2352-4. PubMed ID: 4733686
    [No Abstract]   [Full Text] [Related]  

  • 6. Contents of monoamines in forebrain regions of alcohol-preferring (P) and -nonpreferring (NP) lines of rats.
    Murphy JM; McBride WJ; Lumeng L; Li TK
    Pharmacol Biochem Behav; 1987 Feb; 26(2):389-92. PubMed ID: 2437596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis.
    Pieri L; Keller HH; Burkard W; Da Prada M
    Nature; 1978 Mar; 272(5650):278-80. PubMed ID: 203869
    [No Abstract]   [Full Text] [Related]  

  • 8. The distribution and metabolism of chlorpromazine in rats and the relationship to effects on cerebral monoamine metabolism.
    Wiesel FA; Alfredsson G
    Eur J Pharmacol; 1976 Dec; 40(2):263-72. PubMed ID: 991935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal profile of levels of monoamines and their metabolites in striata of rats implanted with dialysis tubes.
    Reiriz J; Mena MA; Bazán E; Muradás V; Lerma J; Delgado JM; De Yébenes JG
    J Neurochem; 1989 Sep; 53(3):789-92. PubMed ID: 2474632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the ergot alkaloid elymoclavine on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VD; Konstantinova E
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):22-34. PubMed ID: 2428322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain.
    Buckholtz NS; Freedman DX; Middaugh LD
    Eur J Pharmacol; 1985 Mar; 109(3):421-5. PubMed ID: 3987809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of aldehyde oxidase in biogenic amine metabolism.
    Beedham C; Peet CF; Panoutsopoulos GI; Carter H; Smith JA
    Prog Brain Res; 1995; 106():345-53. PubMed ID: 8584671
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding of psychoactive drugs to rat brain amine receptors, measured ex vivo, and their effects on the metabolism of biogenic amines.
    Burki HR
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):258-66. PubMed ID: 2423886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VV; Grahovska T; Petkov VD; Konstantinova E
    Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5HT2 receptor changes in rat cortex and platelets following chronic ritanserin and clorgyline administration.
    Twist EC; Mitchell S; Brazell C; Stahl SM; Campbell IC
    Biochem Pharmacol; 1990 Jan; 39(1):161-6. PubMed ID: 1688704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of repeated D-lysergic acid diethylamide injections on catecholamine levels and tyrosine hydroxylase activity in rat brain regions.
    Peters DA; Tang S
    J Neurochem; 1977 Jan; 28(1):59-62. PubMed ID: 13158
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modification of aminergic neurotransmitters and neurobehavioral correlates in acute cerebral ischemia in the rat].
    Bentué-Ferrer D; Reymann JM; Van den Driessche J; Bagot H; Allain H
    J Pharmacol; 1986; 17(4):578-84. PubMed ID: 2436009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin enhances the effects of nimodipine on biogenic amines of rat brain.
    Gaggi R; Chirivi L; Roncada P; Gianni AM
    Gen Pharmacol; 1992 May; 23(3):561-3. PubMed ID: 1380937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of praziquantel on monoamine transmitters in the rat brain].
    Liu GQ; Ma ZQ; Yang XJ; Jiang Y; Xie L
    Yao Xue Xue Bao; 1985 Nov; 20(11):807-10. PubMed ID: 2424264
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic lysergic acid diethylamide administration and serotonin turnover in various regions of the rat brain.
    Peters DA
    J Neurochem; 1974 Oct; 23(4):625-8. PubMed ID: 4430908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.